Objective
T2D, type 2 diabetes, P.
TYPE 2 DIABETES
Edited by: Qi Pan, Peking University, ChinaReviewed by: Peng Yu, Fudan University, China; Sudhanshu Kumar Bharti, Patna University, India; Vivek P. Chavda, L. M. College of Pharmacy, India†These authors have contributed equally to this workThis prospective study aimed to evaluate the effect of beinaglutide combined with metformin versus aspart 30 with metformin on metabolic profiles and antidrug antibodies (ADAs) in patients with type 2 diabetes (T2D).